GE HealthCare Technologies
87,33$
-0,01 (-0,01%)
22.01.2025, 23:02:34 Uhr
WKN: A3D3G6 ISIN: US36266G1076 Wertpapiertyp: Aktie Währung: US-Dollar
- 1T
- 1W
- 1M
- 3M
- 6M
- 1J
- 3J
- 5J
- 10J
- Max
Weltmärkte
- DAX ® +212,27 +1,01% 21.254,27
- MDAX ® +83,25 +0,32% 26.055,92
- TecDAX ® +21,70 +0,60% 3.663,55
- E-STOXX 50 ® +39,87 +0,77% 5.205,83
- NASDAQ 100 +286,49 +1,33% 21.853,00
- HANG SENG -358,28 -1,78% 19.778,77
Kursperformance
Zeitraum | Kurs | % |
---|---|---|
1 Tag | 87,34$ | -0,01% |
1 Woche | 84,13$ | +3,82% |
1 Monat | 78,88$ | +10,73% |
6 Monate | 80,38$ | +8,66% |
Lfd. Jahr (YTD) | 78,15$ | +11,76% |
1 Jahr | 74,00$ | +18,02% |
3 Jahre | -- | -- |
5 Jahre | -- | -- |
Kursdaten
Kurs | 87,33$ |
Schluss Vortag | 87,34$ |
Eröffnung | 87,22$ |
Geld | 85,65$ |
Brief | 87,50$ |
Tages-Hoch | 88,27$ |
Tages-Tief | 86,75$ |
52 Wochen-Hoch | 94,55$ |
52 Wochen-Tief | 71,31$ |
Allzeit-Hoch | 94,55$ |
Allzeit-Tief | 53,50$ |
Nachrichten
- BUSINESS WIRE: GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical - 02.12.2024, 05:45:26 Uhr
- BUSINESS WIRE: GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent - 07.10.2024, 08:30:06 Uhr